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Blood stage P. falciparum (Pf) accumulates hemozoin
(HZ), the crystal of dimerized undigested heme. HZ
wrapped up in the food vacuole membrane binds satu-
rated and polyunsaturated fatty acids (PUFA) and pro-
teins, generates bioactive ligands and is expelled in the
blood during schizogony as residual body. HZ contains
redox active iron that peroxidizes PUFA to produce
bioactive hydroxy-PUFA (HETEs; HODEs) and terminal
aldehydes (4-hydroxynonenal, HNE). HETEs is responsi-
ble for some of the HZ effects: (1) down-modulation of
oxidative burst; (2) inhibition of dendritic cells (DC) dif-
ferentiation-maturation; and (3) enhancement of expres-
sion and enzyme activity of metalloproteinase MMP-9.
Low-micromolar HETE recapitulated effects (2) and (3).
Recapitulation was abrogated by PPAR-gamma-receptor
inhibitors.
Other effects, such as inhibition of erythropoiesis,
w e r ed u et ot h et r a n s f e ro fH N Et od i f f e r e n t i a t i n g
human erythroid precursors. Erythropoiesis was inhib-
ited by transferred HNE via blockage of cell cycle and
the down-regulation of protein expression of crucial
receptors (erythropoietinR, transferrinR and stem-cell-
factorR). Malarial dyserythropoiesis, which plays an
important role in malaria anaemia (MA) is characterized
by (1) decreased growth and differentiation of erythroid
precursors; (2) low reticulocyte response; and (3) normal
production of erythropoietin (EPO). In human bone
marrow (BM) the erythroblastic island (EI) is the ele-
mentary unit of erythropoiesis in which a central macro-
phage (MAC) is surrounded by differentiating erythroid
cells. In malaria anaemia, HZ-laden central MACs are
closely adjacent to developing erythroid cells. HZ and
HZ-laden human monocytes inhibited growth of co-cul-
tivated human erythroid cells and produced HNE that
diffused to adjacent cells generating HNE-protein
adducts. Co-cultivation with HZ or treatment with low-
micromolar HNE inhibited growth of erythroid cells
interfering with cell cycle without apoptosis. Following
HZ/HNE treatment, two critical proteins in cell cycle
regulation, p53 and p21, were increased and the retino-
blastoma protein, central regulator of G1-to-S-phase
transition, was consequently hypophosphorylated, while
GATA-1, master transcription factor in erythropoiesis
was reduced. The resul was decreased expression of
cyclin A and D2 retarded cell cycle progression in ery-
throid cells and the K562 cell line. As a second major
effect, HZ and HNE inhibited protein expression of cru-
cial receptors (R): transferrin R1, stem cell factorR,
interleukin-3R and erythropoietinR. The reduced recep-
tor expression and the impaired cell cycle activity
decreased the production of cells expressing glyco-
phorin-A and hemoglobin.
In conclusion, present data confirm the inhibitory role
of HZ, identify HNE as one HZ-generated inhibitory
molecule and describe molecular targets of HNE in
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